These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14705312)

  • 1. Homeless young people are a vulnerable group for hepatitis C.
    Rosenthal DA; Mallett S; Myers P; Rotheram-Borus MJ
    Aust N Z J Public Health; 2003; 27(4):464. PubMed ID: 14705312
    [No Abstract]   [Full Text] [Related]  

  • 2. Substance abuse and high-risk needle-related behaviors among homeless youth in Minneapolis: implications for prevention.
    Lifson AR; Halcón LL
    J Urban Health; 2001 Dec; 78(4):690-8. PubMed ID: 11796815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B and C infections among homeless adolescents.
    Beech BM; Myers L; Beech DJ
    Fam Community Health; 2002 Jul; 25(2):28-36. PubMed ID: 12010113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injection drug use among street youth: a dynamic process.
    Roy E; Lemire N; Haley N; Boivin JF; Frappier JY; Claessens C
    Can J Public Health; 1998; 89(4):239-40. PubMed ID: 9735516
    [No Abstract]   [Full Text] [Related]  

  • 5. The association between residential eviction and syringe sharing among a prospective cohort of street-involved youth.
    Pilarinos A; Kennedy MC; McNeil R; Dong H; Kerr T; DeBeck K
    Harm Reduct J; 2017 May; 14(1):24. PubMed ID: 28499382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada.
    Cunningham EB; Jacka B; DeBeck K; Applegate TL; Harrigan PR; Krajden M; Marshall BD; Montaner J; Lima VD; Olmstead AD; Milloy MJ; Wood E; Grebely J
    Drug Alcohol Depend; 2015 Jul; 152():272-6. PubMed ID: 25977204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008.
    Iversen J; Wand H; Gonnermann A; Maher L;
    Int J Drug Policy; 2010 Nov; 21(6):471-6. PubMed ID: 20472417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Copeman M
    Med J Aust; 2003 Jul; 179(2):119; author reply 119. PubMed ID: 12864712
    [No Abstract]   [Full Text] [Related]  

  • 9. Sex differences in injecting practices and hepatitis C: a systematic review of the literature.
    Roman-Crossland R; Forrester L; Zaniewski G
    Can Commun Dis Rep; 2004 Jul; 30(14):125-32. PubMed ID: 15279499
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk behaviours for infection with HIV and hepatitis C virus among people who inject drugs in Regina, Saskatchewan.
    Hennink M; Abbas Z; Choudhri Y; Diener T; Lloyd K; Archibald CP; Cule S
    Can Commun Dis Rep; 2007 Mar; 33(5):53-9. PubMed ID: 17520768
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biases in surveillance of hepatitis C infection systematically underestimate the etiologic role of tattooing.
    Fischer RP; Haley RW
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1222-3. PubMed ID: 15377309
    [No Abstract]   [Full Text] [Related]  

  • 13. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C among drug users: déjà vu all over again?
    Des Jarlais DC; Schuchat A
    Am J Public Health; 2001 Jan; 91(1):21-2. PubMed ID: 11189818
    [No Abstract]   [Full Text] [Related]  

  • 15. HCV rate high in Baltimore.
    AIDS Patient Care STDS; 1999 Sep; 13(9):571. PubMed ID: 10813045
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands.
    van de Laar TJ; Langendam MW; Bruisten SM; Welp EA; Verhaest I; van Ameijden EJ; Coutinho RA; Prins M
    J Med Virol; 2005 Dec; 77(4):509-18. PubMed ID: 16254983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications of immune protection from hepatitis C infection.
    Aitken CK; Bowden S; Hellard M; Crofts N
    J Urban Health; 2004 Mar; 81(1):58-60. PubMed ID: 15047784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of hepatitis C among a juvenile detention population.
    Feldman GM; Sorvillo F; Cole B; Lawrence WA; Mares R
    J Adolesc Health; 2004 Dec; 35(6):505-8. PubMed ID: 15581531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs.
    Ochnio JJ; Patrick D; Ho M; Talling DN; Dobson SR
    CMAJ; 2001 Aug; 165(3):293-7. PubMed ID: 11517645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C: waiting for the grim reaper.
    Wodak A
    Med J Aust; 1997 Mar; 166(6):284-5. PubMed ID: 9087180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.